You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 300 No. 12, September 24, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •World Health
 •Public Health, Other
 •Quality of Care
 •Patient Safety/ Medical Error
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Risks and Benefits of Importing Prescription Medications From Lower-Income Countries

Irfan A. Dhalla, MD; Allan S. Detsky, MD, PhD

JAMA. 2008;300(12):1453-1455.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Technological progress in communication and transportation has reduced barriers to international trade and revolutionized modern life. Many individuals in North America eat vegetables grown in South America, buy toys produced in China, and receive telephone advice from operators in India. In contrast, health care remains largely a domestic pursuit. Although the international outsourcing of radiology and the importation of prescription drugs1 have received some attention, international trade already plays a larger role in the pharmaceutical sector than most Americans might realize. For example, Americans might be surprised to learn that most prescription medications used in the United States are manufactured abroad. The recent episode linking deaths in the United States to heparin that allegedly was deliberately contaminated during its manufacture in China has properly focused attention on the danger of pharmaceutical globalization. Nevertheless, the benefits of importing prescription medications from lower-income . . . [Full Text of this Article]

Context

Author Affiliations: Departments of Health Policy Management and Evaluation (Dr Detsky) and Medicine (Drs Dhalla and Detsky), University of Toronto; and Department of Medicine, Mount Sinai Hospital and University Health Network (Dr Detsky), Toronto, Ontario, Canada.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.